Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

October 23, 2018

CE Mark Approved for Balt's Magic Glue Cyanoacrylate Liquid Embolic Agent

October 24, 2018—Balt International announced it has received CE Mark approval for Magic Glue, its next-generation cyanoacrylate liquid embolic agent. Magic Glue is indicated for the embolization of arteriovenous malformations. New features of this cyanoacrylate glue include delayed polymerization of the monomers for better control and less adhesion to the microcatheter, allowing for longer injection. Magic Glue is applicable in the fields of neuroradiology and interventional radiology.

According to the company, Magic Glue is a class III implantable medical device that is described as an arterial and venous embolization implant because of its hemostatic action. It is applied in solution with a contrast liquid.

Advertisement

October 24, 2018

FDA Clears Novarad's OpenSight System to Use With Microsoft's HoloLens for Surgical Planning

left-arrow Created with Sketch. Previous Article

October 24, 2018

FDA Clears Novarad's OpenSight System to Use With Microsoft's HoloLens for Surgical Planning

Next Article right-arrow Created with Sketch.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button
)